The EMPOWER observational study of Vormatrigine in Epilepsy.
Latest Information Update: 04 Apr 2025
At a glance
- Drugs Vormatrigine (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms EMPOWER
Most Recent Events
- 24 Mar 2025 According to a Praxis Precision Medicines media release, data from this study will be presented in a Poster presentation (P9-012) on Monday, April 7, 8:00 AM - 9:00 AM PT at the American Academy of Neurology (AAN) 2025 Annual Meeting taking place from April 5 to 9, 2025 in San Diego, California.
- 05 Mar 2025 New trial record
- 28 Feb 2025 According to a Praxis Precision Medicines media release, Early results were shared during the Praxis scientific exhibit at the December 2024 American Epilepsy Society (AES) Annual Meeting, demonstrating significant disease burden compounded by persistent, uncontrolled, often untracked seizures alongside profound psychosocial impact.